Skip to main content

Animations

MJFF Publications

2611 - 2620 of 8816 Results
Title
Year
  • Year
  • 2017
  • 2017
  • 2018
  • 2018
  • 2017
  • 2017
  • 2017
  • 2017
  • 2018
  • 2018
  • Summary Details
    OPEN
    Title: Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia
    Journal Name: Alzheimer's Research & Therapy
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13195-017-0276-4
    Citation Count: 119
  • Summary Details
    OPEN
    Title: O-GlcNAc regulation of autophagy and α-synuclein homeostasis; implications for Parkinson’s disease
    Journal Name: Molecular Brain
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13041-017-0311-1
    Citation Count: 81
  • Summary Details
    OPEN
    Title: TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41593-017-0047-3
    Citation Count: 527
  • Summary Details
    OPEN
    Title: Mutant torsinA in the heterozygous DYT1 state compromises HSV propagation in infected neurons and fibroblasts
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-018-19865-2
    Citation Count: 8
  • Summary Details
    OPEN
    Title: A Bayesian mathematical model of motor and cognitive outcomes in Parkinson’s disease
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc0
    DOI - Digital Object Identifier: 10.1371/journal.pone.0178982
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Role of LRRK2 in the regulation of dopamine receptor trafficking
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0179082
    Citation Count: 67
  • Summary Details
    OPEN
    Title: Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc0
    DOI - Digital Object Identifier: 10.1371/journal.pone.0175674
    Citation Count: 133
  • Summary Details
    OPEN
    Title: Asparagine endopeptidase cleaves α-synuclein and mediates pathologic activities in Parkinson's disease
    Journal Name: Nature Structural & Molecular Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nsmb.3433
    Citation Count: 169
  • Summary Details
    OPEN
    Title: The Effect of Obesity on the Availabilities of Dopamine and Serotonin Transporters
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-018-22814-8
    Citation Count: 43
  • Summary Details
    OPEN
    Title: Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-018-0245-9
    Citation Count: 65
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.